Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 117 | 122 | +5 |
| Shares | 51.4M | 54.4M | +3.03M (+5.9%) |
| Value | $147.8M | $374.5M | +$226.7M (+153.4%) |
New holders (24)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (19)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Shay Capital LLC | 224,305 | $646.0K |
| Verition Fund Management LLC | 65,388 | $188.3K |
| Cubist Systematic Strategies, LLC | 57,070 | $164.4K |
| HRT Financial LP | 50,490 | $145.0K |
| XTX Topco Ltd | 49,878 | $143.6K |
| Algert Global LLC | 36,147 | $104.1K |
| Y-Intercept (Hong Kong) Ltd | 32,086 | $92.4K |
| Corebridge Financial, Inc. | 26,381 | $76.0K |
| SG Americas Securities, LLC | 25,375 | $73.0K |
| Zacks Investment Management | 20,999 | $60.5K |
| Virtu Financial LLC | 13,564 | $39.0K |
| Jain Global LLC | 13,051 | $37.6K |
| Engineers Gate Manager LP | 12,519 | $36.1K |
| CIBC World Markets Corp | 11,949 | $34.4K |
| Jump Financial, LLC | 10,550 | $30.4K |
| Caitong International Asset Management Co., Ltd | 1,507 | $4.34K |
| Steward Partners Investment Advisory, LLC | 790 | $2.27K |
| UBS Asset Management Americas Inc | 703 | $2.02K |
| Coldstream Capital Management Inc | 105 | $302 |